Characterization of the human cysteinyl leukotriene CysLT1 receptor KR Lynch, GP O'neill, Q Liu, DS Im, N Sawyer, KM Metters, N Coulombe, ... Nature 399 (6738), 789-793, 1999 | 1196 | 1999 |
Ecological networks–beyond food webs TC Ings, JM Montoya, J Bascompte, N Blüthgen, L Brown, CF Dormann, ... Journal of animal ecology 78 (1), 253-269, 2009 | 1124 | 2009 |
Characterization of the human cysteinyl leukotriene 2 receptor CE Heise, BF O'Dowd, DJ Figueroa, N Sawyer, T Nguyen, DS Im, ... Journal of Biological Chemistry 275 (39), 30531-30536, 2000 | 850 | 2000 |
Identification of the gene responsible for Best macular dystrophy K Petrukhin, MJ Koisti, B Bakall, W Li, G Xie, T Marknell, O Sandgren, ... Nature genetics 19 (3), 241-247, 1998 | 828 | 1998 |
Receptor for motilin identified in the human gastrointestinal system SD Feighner, CP Tan, KK McKee, OC Palyha, DL Hreniuk, SS Pong, ... Science 284 (5423), 2184-2188, 1999 | 540 | 1999 |
A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy K Zhang, M Kniazeva, M Han, W Li, Z Yu, Z Yang, Y Li, ML Metzker, ... Nature genetics 27 (1), 89-93, 2001 | 530 | 2001 |
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity C Atkins, Q Liu, E Minthorn, SY Zhang, DJ Figueroa, K Moss, TB Stanley, ... Cancer research 73 (6), 1993-2002, 2013 | 500 | 2013 |
N-((1 S)-1-{[4-((2 S)-2-{[(2, 4-dichlorophenyl) sulfonyl] amino}-3-hydroxypropanoyl)-1-piperazinyl] carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a … KS Thorneloe, AC Sulpizio, Z Lin, DJ Figueroa, AK Clouse, GP McCafferty, ... The Journal of pharmacology and experimental therapeutics 326 (2), 432-442, 2008 | 439 | 2008 |
TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development AP Vicari, DJ Figueroa, JA Hedrick, JS Foster, KP Singh, S Menon, ... Immunity 7 (2), 291-301, 1997 | 381 | 1997 |
A role for the melanocortin 4 receptor in sexual function LHT Van der Ploeg, WJ Martin, AD Howard, RP Nargund, CP Austin, ... Proceedings of the National Academy of Sciences 99 (17), 11381-11386, 2002 | 380 | 2002 |
Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes DJ Figueroa, RM Breyer, SK DeFoe, S Kargman, BL Daugherty, ... American journal of respiratory and critical care medicine 163 (1), 226-233, 2001 | 368 | 2001 |
Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2 RN Willette, W Bao, S Nerurkar, T Yue, CP Doe, G Stankus, GH Turner, ... The Journal of pharmacology and experimental therapeutics 326 (2), 443-452, 2008 | 332 | 2008 |
Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression CP Tan, H Sano, H Iwaasa, J Pan, AW Sailer, DL Hreniuk, SD Feighner, ... Genomics 79 (6), 785-792, 2002 | 317 | 2002 |
Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception Q Liu, XM Guan, WJ Martin, TP McDonald, MK Clements, Q Jiang, Z Zeng, ... Journal of Biological Chemistry 276 (40), 36961-36969, 2001 | 311 | 2001 |
Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R AW Sailer, H Sano, Z Zeng, TP McDonald, J Pan, SS Pong, SD Feighner, ... Proceedings of the National Academy of Sciences 98 (13), 7564-7569, 2001 | 309 | 2001 |
Cloning and functional expression of two families of β-subunits of the large conductance calcium-activated K+ channel VN Uebele, A Lagrutta, T Wade, DJ Figueroa, Y Liu, E McKenna, ... Journal of Biological Chemistry 275 (30), 23211-23218, 2000 | 299 | 2000 |
Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized … TK Choueiri, DJ Figueroa, AP Fay, S Signoretti, Y Liu, R Gagnon, K Deen, ... Clinical Cancer Research 21 (5), 1071-1077, 2015 | 279 | 2015 |
Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. JA Hedrick, V Saylor, D Figueroa, L Mizoue, Y Xu, S Menon, J Abrams, ... Journal of immunology (Baltimore, Md.: 1950) 158 (4), 1533-1540, 1997 | 234 | 1997 |
The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy) propyl] sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an … GG Kinney, C Sur, M Burno, PJ Mallorga, JB Williams, DJ Figueroa, ... Journal of Neuroscience 23 (20), 7586-7591, 2003 | 221 | 2003 |
Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury Y Yu, H Jin, D Holder, JS Ozer, S Villarreal, P Shughrue, S Shi, ... Nature biotechnology 28 (5), 470-477, 2010 | 214 | 2010 |